Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9503 | 1082 | 37.8 | 64% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1987 | 5071 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTERSPECIES SCALING | Author keyword | 21 | 51% | 3% | 29 |
2 | DMPK TRANSLAT SCI | Address | 15 | 88% | 1% | 7 |
3 | WELL STIRRED MODEL | Author keyword | 12 | 63% | 1% | 12 |
4 | CLEARANCE PREDICTION | Author keyword | 11 | 57% | 1% | 13 |
5 | VOLUME OF DISTRIBUTION | Author keyword | 10 | 25% | 3% | 34 |
6 | COMPUTATIONAL ADME | Author keyword | 9 | 43% | 1% | 16 |
7 | QSPKR | Author keyword | 8 | 60% | 1% | 9 |
8 | DRUG IONIZATION | Author keyword | 8 | 100% | 0% | 5 |
9 | INTRINSIC CLEARANCE | Author keyword | 8 | 36% | 2% | 18 |
10 | WOODMONT OFF 2 | Address | 8 | 62% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTERSPECIES SCALING | 21 | 51% | 3% | 29 | Search INTERSPECIES+SCALING | Search INTERSPECIES+SCALING |
2 | WELL STIRRED MODEL | 12 | 63% | 1% | 12 | Search WELL+STIRRED+MODEL | Search WELL+STIRRED+MODEL |
3 | CLEARANCE PREDICTION | 11 | 57% | 1% | 13 | Search CLEARANCE+PREDICTION | Search CLEARANCE+PREDICTION |
4 | VOLUME OF DISTRIBUTION | 10 | 25% | 3% | 34 | Search VOLUME+OF+DISTRIBUTION | Search VOLUME+OF+DISTRIBUTION |
5 | COMPUTATIONAL ADME | 9 | 43% | 1% | 16 | Search COMPUTATIONAL+ADME | Search COMPUTATIONAL+ADME |
6 | QSPKR | 8 | 60% | 1% | 9 | Search QSPKR | Search QSPKR |
7 | DRUG IONIZATION | 8 | 100% | 0% | 5 | Search DRUG+IONIZATION | Search DRUG+IONIZATION |
8 | INTRINSIC CLEARANCE | 8 | 36% | 2% | 18 | Search INTRINSIC+CLEARANCE | Search INTRINSIC+CLEARANCE |
9 | HEPATIC CLEARANCE | 8 | 24% | 2% | 27 | Search HEPATIC+CLEARANCE | Search HEPATIC+CLEARANCE |
10 | IN VITRO IN VIVO EXTRAPOLATION | 7 | 30% | 2% | 20 | Search IN+VITRO+IN+VIVO+EXTRAPOLATION | Search IN+VITRO+IN+VIVO+EXTRAPOLATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLASMA PARTITION COEFFICIENTS | 57 | 70% | 4% | 48 |
2 | INTRINSIC CLEARANCE | 54 | 42% | 9% | 98 |
3 | HUMAN DRUG CLEARANCE | 52 | 80% | 3% | 32 |
4 | HEPATIC METABOLIC CLEARANCE | 47 | 81% | 3% | 29 |
5 | ANIMAL DATA | 33 | 75% | 2% | 24 |
6 | IN VITRO DATA | 28 | 31% | 7% | 74 |
7 | HEPATIC CLEARANCE | 24 | 36% | 5% | 54 |
8 | NONSPECIFIC BINDING | 17 | 27% | 5% | 54 |
9 | ANTIPYRINE INTRINSIC CLEARANCE | 17 | 100% | 1% | 8 |
10 | VERTICAL ALLOMETRY | 17 | 100% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data | 2015 | 6 | 55 | 31% |
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science | 2011 | 161 | 164 | 27% |
A novel strategy for physiologically based predictions of human pharmacokinetics | 2006 | 155 | 60 | 77% |
Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches | 2009 | 102 | 44 | 52% |
The application of allometric scaling principles to predict pharmacokinetic parameters across species | 2014 | 5 | 42 | 79% |
The Simcyp (R) Population-based ADME Simulator | 2009 | 123 | 36 | 42% |
Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development: A Pharmaceutical Industry Perspective | 2015 | 1 | 61 | 48% |
Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches | 2013 | 11 | 93 | 54% |
Application of PBPK modelling in drug discovery and development at Pfizer | 2012 | 21 | 93 | 51% |
Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development | 2007 | 45 | 30 | 83% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DMPK TRANSLAT SCI | 15 | 88% | 0.6% | 7 |
2 | WOODMONT OFF 2 | 8 | 62% | 0.7% | 8 |
3 | PL PHARMACOKINET | 8 | 18% | 3.5% | 38 |
4 | DISCOVERY ADME TOX | 3 | 50% | 0.5% | 5 |
5 | CLIN PHARMACOL TOXICOL BRANCH HFD 579 | 3 | 100% | 0.3% | 3 |
6 | THER EUT DRUGS FOOD ANIM HFV 130 | 3 | 100% | 0.3% | 3 |
7 | GLOBAL PK PD PHARMACOMETR | 3 | 45% | 0.5% | 5 |
8 | BLADES ENTERPRISE | 3 | 17% | 1.4% | 15 |
9 | SYST BIOL COMPUTAT SOLUT | 2 | 67% | 0.2% | 2 |
10 | PHARMACEUT EVALUAT 1 | 2 | 30% | 0.6% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000185594 | CYP3A//COCKTAIL//MECHANISM BASED INHIBITION |
2 | 0.0000136297 | BOF 4272//MULTIPLE INDICATOR DILUTION//HEPATIC ELIMINATION |
3 | 0.0000124298 | HUMAN INTESTINAL ABSORPTION//PAMPA//LOG BB |
4 | 0.0000116996 | METHYLHIPPURIC ACID//HIPPURIC ACID//PBPK MODELING |
5 | 0.0000096328 | OATP1B1//SLCO1B1//OATP |
6 | 0.0000093831 | ORAL PHARMACOL THER EUT//PHARMACEUT SCI BIOPHARMACEUT MIZUHO KU//31 TANABE DORIMIZUHO KU |
7 | 0.0000084792 | INO 2628 CZ//DOUBLE PEAKS//DISCONTINUOUS ABSORPTION |
8 | 0.0000083553 | P PHENYLBENZOIC ACID//CPDPN//DEVELOPING FETUS |
9 | 0.0000078696 | LIVER SLICES//PRECISION CUT TISSUE SLICES//PRECISION CUT LIVER SLICES |
10 | 0.0000077837 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//DISTRIBUTION CLEARANCE//CURVE MOMENTS |